• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Presenting on the Emerging Growth Conference 64 Day 1 on November 1 Register Now

    10/31/23 7:00:00 AM ET
    $AGBA
    $AMPE
    $CING
    $COCH
    Investment Managers
    Finance
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $AGBA alert in real time by email

    MIAMI, Oct. 31, 2023 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 64th Emerging Growth Conference on November 1st and 2nd, 2023.

    The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth.

    Register for the conference here.

    Submit Questions for any of the presenting companies to:

    [email protected]

    For updates, follow us on Twitter

    Day 1

    November 1, 2023

    8:45

    Virtual Lobby opens.

    Register for the Conference. If you already registered, go back to the registration link and click "Already registered" and enter your email.

    9:00

    Introduction

    9:05 - 9:35

    AGBA Group Holding Limited (NASDAQ:AGBA)

    Keynote speaker: Mr. Wing-Fai Ng, Group President of AGBA Group

    9:40 - 10:10

    Battery Mineral Resources Corp., (OTCQB:BTRMF) (TSXV:BMR)

    KeKeynote speaker: Martin Kostuik, President / CEO

    10:15 - 10:45

    Envoy Medical, Inc. (NASDAQ:COCH)

    Keynote speaker: Brent Lucas, CEO & David R. Wells, CFO

    10:50 - 11:20

    Houston Natural Resources Corp. (OTC:HNRC)

    Keynote speaker: Frank Kristan, Chairman & CEO

    11:25 - 11:55

    Electronic Servitor Publication Network Inc. (OTCQB:XESP)

    Keynote speaker: Peter Hager, President / CEO

    12:00 - 12:30

    Jaguar Health, Inc. (NASDAQ:JAGX)

    Keynote speaker: Lisa A. Conte, Founder, CEO, President & Director

    12:35 - 1:05

    Ocean Biomedical, Inc. (NASDAQ:OCEA)

    Keynote speakers:

    Dr. Chirinjeev Kathuria, Co-founder / Chairman,

    Elizebeth Ng, CEO,

    Dr. Jonathan Kurtis, Scientific Co-founder & Director of the MD/PhD program Brown University,

    Gurinder Kalra, CFO,

    Daniel Behr, EVP of Academic Partnerships,

    Dr. Inderjote Kathuria, Chief Strategy Officer

    1:10 - 1:40

    GPO Plus, Inc. (OTCQB:GPOX)

    Keynote speaker: Brett Pojunis, President / CEO

    Postponed to December 6

    Coeptis Therapeutics Holdings, Inc. (NASDAQ:COEP)

    Keynote speaker: David Mehalick, President / CEO

    2:20 - 2:50

    Regen BioPharma Inc. (OTC:RGBP)

    Keynote speakers: David Koos, President / CEO & Harry M. Lander, Ph.D. Senior Scientific Consultant

    2:55 - 3:05

    Renforth Resources, Inc. (OTCQB:RFHRF) (CSE:RFR)

    Keynote speaker: Nicole Brewster, President & CEO

    3:10 - 3:20

    Ideal Power (NASDAQ:IPWR)

    Keynote speaker: Dan Brdar, President / CEO, & Tim Burns, CFO

    3:25 - 3:35

    Steppe Gold, Ltd. (OTCQX:STPGF) (TSX:STGO)

    Keynote speakers: Aneel Singh, Exec. VP & Director

    3:40 - 3:50

    NeuroMetrix, Inc. (NASDAQ:NURO)

    Keynote speaker: Dr. Shai Gozani, CEO & Thomas Higgins, CFO

    3:55 - 4:05

    RedCloud Technologies, a Private Company

    Keynote speaker: Justin Floyd, CEO

    Day 2

    November 2, 2023

    10:00

    Virtual Lobby opens.

    Register for the Conference. If you already registered, go back to the registration link and click "Already registered" and enter your email.

    9:35

    Introduction

    10:15 - 10:45

    Sonim Technologies, Inc. (NASDAQ:SONM)

    Keynote speaker: Hao Liu, CEO

    10:50 - 11:20

    Quantum Computing Inc., (NASDAQ:QUBT)

    Keynote speakers: Robert Liscouski, CEO, & Chris Boehmler, CFO

    11:25 - 11:55

    Gold Terra Resource Corp. (OTCQX:YGTFF) (TSXV:YGT)

    Keynote speaker: Gerald Sylvain Panneton, CEO

    12:00 - 12:30

    Independence Contract Drilling, Inc. (NYSE:ICD)

    Keynote speaker: Anthony Gallegos, President / CEO & Director

    12:35 - 1:05

    BioHarvest Sciences Inc. (OTCQB:CNVCF) (CSE:BHSC)

    Keynote speaker: Ilan Sobel, CEO

    1:10 - 1:40

    Ampio Pharmaceuticals, Inc. (NYSE:AMPE)

    Keynote speaker: Michael Martino, CEO & Director

    1:45 - 2:15

    Medicus Pharma Ltd. (TSXV:MDCX)

    Keynote speaker: Carolyn Bonner, President

    Postponed to December 6

    Cingulate Inc. (NASDAQ:CING)

    Keynote speaker: Shane Schaffer, CEO

    2:55 - 3:05

    Loop Industries, Inc. (NASDAQ:LOOP)

    Keynote speaker: Kevin C. O'Dowd, VP Communications

    3:10 - 3:20

    Theriva Biologics Inc., (NYSE:TOVX)

    Keynote speaker: Dr. Manel Cascallo', General Director

    3:25 - 3:35

    Alpha Tau Medical, Inc. (NASDAQ:DRTS)

    eynote speaker: Raphi Levy, CFO

    3:55 - 4:05

    GeoVax Labs, Inc. (NASDAQ:GOVX)

    Keynote speaker: David Dodd, Chairman, President / CEO

    Visit the following link to register. You will then receive an email containing the link and time to sign into the conference.

    Register for the conference here.

    Submit Questions for any of the presenting companies to:

    [email protected]

    Replays: Subscribe to our YouTube Channel

    About EmergingGrowth.com

    Founded in 2009, Emerging Growth.com quickly became a leader in its space and has developed an extensive history of identifying emerging growth companies that can be overlooked by the investment community.

    About the Emerging Growth Conference

    The Emerging Growth Conference is an effective way for public companies to engage with the investment community regarding their Company, new products, services and other major announcements from anywhere, in an effective and time efficient manner.

    All sessions are conducted through video webcasts. Our conference serves as a vehicle for Emerging Growth to build relationships with our existing and potential clients. Accordingly, a certain number of the presenting companies are our current clients, and some may become our clients in the future. In exchange for services we provide, our clients pay us fees in the form of cash and securities, and we may currently have, or in the future may have investments in the securities of certain of the presenting companies. Finally, certain of the presenting companies have paid us a fee to secure a presentation time slot or to present generally. The presentations to be delivered by the presenting companies (including any virtual handouts of written materials) have not been approved, endorsed by or otherwise reviewed by EmergingGrowth.com nor should they in any way be construed to have been made in connection with an offer to sell or a solicitation of an offer to buy securities. Please consult an investment professional before investing in anything viewed on the Emerging Growth Conference or on EmergingGrowth.com.

    If you believe or know of a company that might fit our audience, contact us here.

    Thank you for your interest in our conference, and we look forward to your participation in future conferences.

    Contact:

    Emerging Growth

    Phone: 1-305-330-1985

    Email: [email protected]



    Primary Logo

    Get the next $AGBA alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AGBA
    $AMPE
    $CING
    $COCH

    CompanyDatePrice TargetRatingAnalyst
    Alpha Tau Medical Ltd.
    $DRTS
    3/4/2026$5.00Overweight → Neutral
    Piper Sandler
    GeoVax Labs Inc.
    $GOVX
    2/19/2026Buy → Hold
    D. Boral Capital
    Quantum Computing Inc.
    $QUBT
    1/15/2026$22.00Buy
    Rosenblatt
    Quantum Computing Inc.
    $QUBT
    12/17/2025$12.00Neutral
    Wedbush
    Quantum Computing Inc.
    $QUBT
    9/18/2025$24.00Buy
    Lake Street
    Quantum Computing Inc.
    $QUBT
    7/2/2025$15.00Neutral
    Cantor Fitzgerald
    GeoVax Labs Inc.
    $GOVX
    4/15/2025$18.00 → $14.00Buy
    D. Boral Capital
    GeoVax Labs Inc.
    $GOVX
    4/15/2025$15.00 → $8.50Buy
    Alliance Global Partners
    More analyst ratings

    $AGBA
    $AMPE
    $CING
    $COCH
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President and CEO Somo David M bought $250,000 worth of shares (90,909 units at $2.75), increasing direct ownership by 37% to 338,347 units (SEC Form 4)

    4 - Ideal Power Inc. (0001507957) (Issuer)

    2/26/26 8:49:32 AM ET
    $IPWR
    Semiconductors
    Technology

    Director Patel Mona Chetan bought $125,000 worth of shares (312,500 units at $0.40), increasing direct ownership by 1,562% to 332,500 units (SEC Form 4)

    4 - Envoy Medical, Inc. (0001840877) (Issuer)

    2/17/26 4:51:51 PM ET
    $COCH
    Industrial Specialties
    Health Care

    Interim CFO Potashnick Robert bought $85,000 worth of shares (212,500 units at $0.40) (SEC Form 4)

    4 - Envoy Medical, Inc. (0001840877) (Issuer)

    2/17/26 4:49:33 PM ET
    $COCH
    Industrial Specialties
    Health Care

    $AGBA
    $AMPE
    $CING
    $COCH
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Envoy Medical Reports Full Year 2025 Financial Results

    Received FDA approval to expand fully implanted Acclaim® Cochlear Implant Pivotal Clinical Trial to final stageStrengthened balance sheet by extinguishing $32 million in debtSubsequent to year-end, closed on transformational capital raise led by established institutional healthcare investors and completed enrollment of Pivotal Clinical Trial for first-of-its-kind fully implanted cochlear implantWhite Bear Lake, Minnesota--(Newsfile Corp. - March 23, 2026) - Envoy Medical® Inc. (NASDAQ:COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering fully implanted hearing solutions, today announced its corporate and financial results for the full year ended December 31, 2025, as

    3/23/26 8:30:00 AM ET
    $COCH
    Industrial Specialties
    Health Care

    Theriva™ Biologics Announces Positive End-of-Phase 2 Meeting with U.S. FDA Regarding the Design of a Phase 3 Trial of VCN-01 in Metastatic Pancreatic Ductal Adenocarcinoma

    – Successful meeting with FDA enables advancement into proposed Phase 3 clinical trial of VCN-01 in combination with gemcitabine/nab-paclitaxel for the first-line treatment of metastatic PDAC – – Combined feedback from FDA and previously from EMA enables company to finalize protocol for pivotal Phase 3 clinical trial while pursuing strategic funding opportunities ROCKVILLE, Md., March 23, 2026 (GLOBE NEWSWIRE) -- Theriva™ Biologics (NYSE:TOVX), a diversified clinical-stage company developing therapeutics designed to treat cancer and related diseases in areas of high unmet need, today announced the outcomes of a recent Type B End-of-Phase 2 (EOP2) meeting with the U.S. Food and Drug

    3/23/26 8:00:00 AM ET
    $TOVX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    The Race to Shield Global Infrastructure from the Coming Quantum Threat

    Issued on behalf of Quantum Secure Encryption Corp.VANCOUVER, BC, March 19, 2026 /CNW/ -- USANewsGroup.com News Commentary -- Think of it as a "digital heist" happening in slow motion. Bad actors are currently grabbing encrypted data with the plan to unlock it once quantum computers go mainstream. It is no longer a theoretical "maybe" scenario; it is an active operational risk. The World Economic Forum recently warned that this "harvest-now-decrypt-later" strategy is already well underway[1]. For the people running our power grids and water systems, the clock is ticking because their heavy-duty tech takes years, not months, to update[2]. This massive structural shift is opening doors for Qua

    3/19/26 11:39:00 AM ET
    $CIEN
    $NET
    $QUBT
    Telecommunications Equipment
    Utilities
    Computer Software: Prepackaged Software
    Technology

    $AGBA
    $AMPE
    $CING
    $COCH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Alpha Tau downgraded by Piper Sandler with a new price target

    Piper Sandler downgraded Alpha Tau from Overweight to Neutral and set a new price target of $5.00

    3/4/26 8:30:52 AM ET
    $DRTS
    Medical/Dental Instruments
    Health Care

    GeoVax Labs downgraded by D. Boral Capital

    D. Boral Capital downgraded GeoVax Labs from Buy to Hold

    2/19/26 8:44:06 AM ET
    $GOVX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Rosenblatt initiated coverage on Quantum Computing with a new price target

    Rosenblatt initiated coverage of Quantum Computing with a rating of Buy and set a new price target of $22.00

    1/15/26 8:40:11 AM ET
    $QUBT
    Computer Software: Prepackaged Software
    Technology

    $AGBA
    $AMPE
    $CING
    $COCH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Avruch Michael

    3 - Alpha Tau Medical Ltd. (0001871321) (Issuer)

    3/18/26 7:04:47 PM ET
    $DRTS
    Medical/Dental Instruments
    Health Care

    SEC Form 3 filed by new insider Kidron Nadav

    3 - Alpha Tau Medical Ltd. (0001871321) (Issuer)

    3/18/26 7:04:07 PM ET
    $DRTS
    Medical/Dental Instruments
    Health Care

    SEC Form 3 filed by new insider Sofer Uzi

    3 - Alpha Tau Medical Ltd. (0001871321) (Issuer)

    3/18/26 7:03:38 PM ET
    $DRTS
    Medical/Dental Instruments
    Health Care

    $AGBA
    $AMPE
    $CING
    $COCH
    SEC Filings

    View All

    SEC Form EFFECT filed by Cingulate Inc.

    EFFECT - Cingulate Inc. (0001862150) (Filer)

    3/25/26 12:15:14 AM ET
    $CING
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Cingulate Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Submission of Matters to a Vote of Security Holders

    8-K - Cingulate Inc. (0001862150) (Filer)

    3/24/26 5:14:49 PM ET
    $CING
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 424B3 filed by Cingulate Inc.

    424B3 - Cingulate Inc. (0001862150) (Filer)

    3/24/26 5:13:25 PM ET
    $CING
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AGBA
    $AMPE
    $CING
    $COCH
    Financials

    Live finance-specific insights

    View All

    Theriva™ Biologics Reports Full-Year 2025 Operational Highlights and Financial Results

    - Advancing clinical development of VCN-01 for pancreatic ductal adenocarcinoma and retinoblastoma - - Licensed SYN-020 to Rasayana Therapeutics for development in multiple indications; up to $38 million in potential milestones plus royalties on commercial sales - - Cash and cash equivalents of $13.1 million as of December 31, 2025; recent capital raises increase cash to $15.2 million as of February 26, 2026 and provides cash runway into Q1 2027- ROCKVILLE, M.D., March 12, 2026 (GLOBE NEWSWIRE) -- Theriva™ Biologics, Inc. (NYSE:TOVX), a diversified clinical-stage company developing therapeutics designed to treat cancer and related diseases in areas of high unmet need, today reported fin

    3/12/26 8:00:00 AM ET
    $TOVX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Quantum Computing Inc. Reports Fourth Quarter and Year-End 2025 Financial Results

    HOBOKEN, N.J., March 2, 2026 /PRNewswire/ -- Quantum Computing Inc. ("QCi" or the "Company") (NASDAQ:QUBT), an innovative, quantum optics and integrated photonics technology company, today released financial results for the three and twelve-month periods ended December 31, 2025.Dr. Yuping Huang, Chief Executive Officer of QCi, commented, "In 2025 we continued to advance our strategy to build a vertically integrated photonics and quantum optics platform capable of supporting scalable, commercial applications across AI, high-performance computing, cybersecurity, and remote sensing.  We completed and opened "Fab 1", our TFLN chip manufacturing facility in Tempe, Arizona, expanded our foundry se

    3/2/26 4:05:00 PM ET
    $QUBT
    Computer Software: Prepackaged Software
    Technology

    Ideal Power to Host Fourth Quarter and Full Year 2025 Results Conference Call on March 10, 2026 at 10:00 AM Eastern Time

    AUSTIN, Texas, Feb. 27, 2026 /PRNewswire/ -- Ideal Power Inc. (NASDAQ:IPWR) ("Ideal Power," the "Company," "we," "us" or "our"), developer and provider of its innovative and widely patented B-TRAN® bidirectional semiconductor power switch, today announced management will hold a conference call on Tuesday, March 10, 2026 at 10:00 AM Eastern Time to discuss its results for the fourth quarter and full year ended December 31, 2025. A press release detailing these results will be issued prior to the call.Ideal Power management will host the conference call, followed by a question-and-answer period. Analysts and investors may pose questions for management during the live conference call on March 1

    2/27/26 9:20:00 AM ET
    $IPWR
    Semiconductors
    Technology

    $AGBA
    $AMPE
    $CING
    $COCH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Cingulate Inc.

    SC 13G/A - Cingulate Inc. (0001862150) (Subject)

    11/14/24 7:21:05 PM ET
    $CING
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by GeoVax Labs Inc.

    SC 13G/A - GeoVax Labs, Inc. (0000832489) (Subject)

    11/14/24 5:10:48 PM ET
    $GOVX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Coeptis Therapeutics Holdings Inc.

    SC 13G/A - Coeptis Therapeutics Holdings, Inc. (0001759186) (Subject)

    11/14/24 3:59:49 PM ET
    $COEP
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AGBA
    $AMPE
    $CING
    $COCH
    Leadership Updates

    Live Leadership Updates

    View All

    Mainz Biomed Announces Appointment of Robert Liscouski as Chairman of the Board of Directors

    BERKELEY, Calif., March 11, 2026 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ), a molecular genetics diagnostic company specializing in the early detection of cancer, today announced that Robert P. Liscouski has been appointed Chairman of its Board of Directors. Further, the Company announced that it plans to change its name to Quantum Cyber and change its Nasdaq ticker symbol to QUCY, beginning on March 12, 2026. The permanent election of Mr. Liscouski and the change of Company name will become effective at the Company's extraordinary general meeting, being planned for April 2026. The Company will begin doing business as Quantum Cyber and trading under the symbol QUCY beginning on M

    3/11/26 7:30:00 AM ET
    $MYNZ
    $QUBT
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Computer Software: Prepackaged Software
    Technology

    Quantum Computing Inc. Completes Acquisition of NuCrypt to Advance Quantum Communications Commercialization

    HOBOKEN, N.J., March 5, 2026 /PRNewswire/ -- Quantum Computing Inc. ("QCi" or the "Company") (NASDAQ:QUBT), an innovative, quantum optics and integrated photonics technology company, today announced the completion of its acquisition of NuCrypt, LLC ("NuCrypt"), a quantum communications technology company, in a transaction valued at $5 million, to be paid in a combination of cash and shares of QCi common stock (the "Transaction").The acquisition helps establish quantum communications as an important commercialization vertical within QCi's broader quantum technology strategy. By integrating NuCrypt's suite of quantum communications systems and products, QCi expects to advance its technology ro

    3/5/26 8:30:00 AM ET
    $QUBT
    Computer Software: Prepackaged Software
    Technology

    Quantum Computing Inc. Confirms Dr. Yuping Huang as Chief Executive Officer to Lead Global Growth

    HOBOKEN, N.J., Dec. 17, 2025 /PRNewswire/ -- Quantum Computing Inc. ("QCi" or the "Company") (NASDAQ:QUBT), an innovative, quantum optics and integrated photonics technology company, today announced a leadership update with the appointment of Dr. Yuping Huang as Chief Executive Officer ("CEO"), effective January 1st, 2026. Dr. Huang was appointed as QCi's Interim CEO on April 11, 2025. This appointment comes as part of QCi's ongoing focus on growth and scaling its quantum photonics systems for industrial and commercial use. Dr. Huang's appointment marks a pivotal moment as QCi moves from prototype development and small-batch manufacturing toward industrial-scale manufacturing production. The

    12/17/25 8:30:00 AM ET
    $QUBT
    Computer Software: Prepackaged Software
    Technology